Table 3.
Comorbidities of the total study population and echocardiographic measurements at visit 1.
| Comorbidities | n (%) |
|---|---|
| Coronary artery disease | 330 (18.2%) |
| Coronary artery disease w/o infarction | 172 (9.5%) |
| History of myocardial infarction | 158 (8.7%) |
| Heart failure | 88 (4.8%) |
| Cardiac rhythm disorders | 156 (8.6%) |
| Arterial hypertension | 1020 (56.1%) |
| Asthma | 334 (18.4%) |
| Sleep apnoea | 201 (11.1%) |
| Diabetes | 236 (13.0%) |
| Hyperlipidaemia | 804 (44.2%) |
| Hyperuricaemia | 334 (18.4%) |
| Osteoporosis | 281 (15.5%) |
| Psychological disorders | 437 (24.1%) |
| Echocardiographic measurements (n = 1347) | |
| LVEDD (mm) | 48.11 ± 7.01 |
| LVESD (mm) | 32.21 ± 7.15 |
| LVEF (%) | 61.59 ± 9.07 |
| LA (mm) | 36.03 ± 6.37 |
The echocardiographic measures are given as mean values and standard deviations; the number of patients with impairments is given in the Results. LVEDD = left ventricular end-diastolic diameter; LVESD = left ventricular end-systolic diameter; LVEF = left ventricular ejection fraction, LA = left atrial diameter.